nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—HTR1B—dura mater—ankylosing spondylitis	0.127	0.442	CbGeAlD
Cabergoline—HTR1D—dura mater—ankylosing spondylitis	0.123	0.428	CbGeAlD
Cabergoline—HTR2A—vertebral column—ankylosing spondylitis	0.0184	0.0639	CbGeAlD
Cabergoline—HTR2B—tendon—ankylosing spondylitis	0.00498	0.0173	CbGeAlD
Cabergoline—HTR7—tendon—ankylosing spondylitis	0.00426	0.0148	CbGeAlD
Cabergoline—ADRA2C—tendon—ankylosing spondylitis	0.00392	0.0136	CbGeAlD
Cabergoline—ADRA2A—tendon—ankylosing spondylitis	0.00312	0.0109	CbGeAlD
Cabergoline—Sweating increased—Betamethasone—ankylosing spondylitis	0.00299	0.00419	CcSEcCtD
Cabergoline—Face oedema—Prednisone—ankylosing spondylitis	0.00298	0.00419	CcSEcCtD
Cabergoline—Epistaxis—Triamcinolone—ankylosing spondylitis	0.00284	0.00399	CcSEcCtD
Cabergoline—Visual impairment—Prednisolone—ankylosing spondylitis	0.00284	0.00398	CcSEcCtD
Cabergoline—Weight increased—Betamethasone—ankylosing spondylitis	0.00279	0.00392	CcSEcCtD
Cabergoline—Weight increased—Dexamethasone—ankylosing spondylitis	0.00279	0.00392	CcSEcCtD
Cabergoline—Weight decreased—Dexamethasone—ankylosing spondylitis	0.00277	0.00389	CcSEcCtD
Cabergoline—Weight decreased—Betamethasone—ankylosing spondylitis	0.00277	0.00389	CcSEcCtD
Cabergoline—Rhinitis—Triamcinolone—ankylosing spondylitis	0.00271	0.00381	CcSEcCtD
Cabergoline—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.00271	0.0038	CcSEcCtD
Cabergoline—Hallucination—Methylprednisolone—ankylosing spondylitis	0.00269	0.00377	CcSEcCtD
Cabergoline—HTR2A—tendon—ankylosing spondylitis	0.00266	0.00924	CbGeAlD
Cabergoline—Arrhythmia—Prednisolone—ankylosing spondylitis	0.00263	0.00369	CcSEcCtD
Cabergoline—Sweating increased—Prednisone—ankylosing spondylitis	0.0026	0.00365	CcSEcCtD
Cabergoline—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.0026	0.00365	CcSEcCtD
Cabergoline—Osteoarthritis—Methotrexate—ankylosing spondylitis	0.00258	0.00362	CcSEcCtD
Cabergoline—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00251	0.00352	CcSEcCtD
Cabergoline—Hallucination—Dexamethasone—ankylosing spondylitis	0.00244	0.00343	CcSEcCtD
Cabergoline—Hallucination—Betamethasone—ankylosing spondylitis	0.00244	0.00343	CcSEcCtD
Cabergoline—Weight increased—Prednisone—ankylosing spondylitis	0.00243	0.00341	CcSEcCtD
Cabergoline—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00242	0.00339	CcSEcCtD
Cabergoline—Weight decreased—Prednisone—ankylosing spondylitis	0.00242	0.00339	CcSEcCtD
Cabergoline—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00241	0.00338	CcSEcCtD
Cabergoline—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.00238	0.00335	CcSEcCtD
Cabergoline—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00238	0.00334	CcSEcCtD
Cabergoline—Depression—Prednisone—ankylosing spondylitis	0.00237	0.00333	CcSEcCtD
Cabergoline—Visual impairment—Dexamethasone—ankylosing spondylitis	0.00237	0.00332	CcSEcCtD
Cabergoline—Visual impairment—Betamethasone—ankylosing spondylitis	0.00237	0.00332	CcSEcCtD
Cabergoline—Malaise—Prednisolone—ankylosing spondylitis	0.00231	0.00324	CcSEcCtD
Cabergoline—Vertigo—Prednisolone—ankylosing spondylitis	0.0023	0.00323	CcSEcCtD
Cabergoline—Syncope—Prednisolone—ankylosing spondylitis	0.0023	0.00322	CcSEcCtD
Cabergoline—Back pain—Triamcinolone—ankylosing spondylitis	0.00228	0.0032	CcSEcCtD
Cabergoline—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00225	0.00316	CcSEcCtD
Cabergoline—Hypertension—Prednisolone—ankylosing spondylitis	0.00221	0.0031	CcSEcCtD
Cabergoline—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.00219	0.00308	CcSEcCtD
Cabergoline—Arrhythmia—Betamethasone—ankylosing spondylitis	0.00219	0.00308	CcSEcCtD
Cabergoline—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00219	0.00307	CcSEcCtD
Cabergoline—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00218	0.00306	CcSEcCtD
Cabergoline—Alopecia—Betamethasone—ankylosing spondylitis	0.00217	0.00304	CcSEcCtD
Cabergoline—Alopecia—Dexamethasone—ankylosing spondylitis	0.00217	0.00304	CcSEcCtD
Cabergoline—Discomfort—Prednisolone—ankylosing spondylitis	0.00215	0.00302	CcSEcCtD
Cabergoline—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.00214	0.003	CcSEcCtD
Cabergoline—Hallucination—Prednisone—ankylosing spondylitis	0.00213	0.00299	CcSEcCtD
Cabergoline—Malaise—Triamcinolone—ankylosing spondylitis	0.00212	0.00298	CcSEcCtD
Cabergoline—Malaise—Methylprednisolone—ankylosing spondylitis	0.00212	0.00297	CcSEcCtD
Cabergoline—Vertigo—Triamcinolone—ankylosing spondylitis	0.00212	0.00297	CcSEcCtD
Cabergoline—Syncope—Triamcinolone—ankylosing spondylitis	0.00211	0.00296	CcSEcCtD
Cabergoline—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00211	0.00296	CcSEcCtD
Cabergoline—Syncope—Methylprednisolone—ankylosing spondylitis	0.00211	0.00296	CcSEcCtD
Cabergoline—Oedema—Prednisolone—ankylosing spondylitis	0.00209	0.00293	CcSEcCtD
Cabergoline—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.00207	0.00291	CcSEcCtD
Cabergoline—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00207	0.00291	CcSEcCtD
Cabergoline—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00207	0.0029	CcSEcCtD
Cabergoline—Shock—Prednisolone—ankylosing spondylitis	0.00206	0.00289	CcSEcCtD
Cabergoline—Hypertension—Triamcinolone—ankylosing spondylitis	0.00203	0.00285	CcSEcCtD
Cabergoline—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00203	0.00285	CcSEcCtD
Cabergoline—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00202	0.00284	CcSEcCtD
Cabergoline—Pneumonia—Methotrexate—ankylosing spondylitis	0.002	0.00281	CcSEcCtD
Cabergoline—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.002	0.00281	CcSEcCtD
Cabergoline—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00199	0.0028	CcSEcCtD
Cabergoline—Depression—Methotrexate—ankylosing spondylitis	0.00198	0.00279	CcSEcCtD
Cabergoline—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00198	0.00278	CcSEcCtD
Cabergoline—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00198	0.00278	CcSEcCtD
Cabergoline—Discomfort—Triamcinolone—ankylosing spondylitis	0.00198	0.00278	CcSEcCtD
Cabergoline—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00198	0.00277	CcSEcCtD
Cabergoline—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00196	0.00275	CcSEcCtD
Cabergoline—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00193	0.00271	CcSEcCtD
Cabergoline—Malaise—Dexamethasone—ankylosing spondylitis	0.00193	0.0027	CcSEcCtD
Cabergoline—Malaise—Betamethasone—ankylosing spondylitis	0.00193	0.0027	CcSEcCtD
Cabergoline—Oedema—Triamcinolone—ankylosing spondylitis	0.00192	0.0027	CcSEcCtD
Cabergoline—Vertigo—Dexamethasone—ankylosing spondylitis	0.00192	0.00269	CcSEcCtD
Cabergoline—Vertigo—Betamethasone—ankylosing spondylitis	0.00192	0.00269	CcSEcCtD
Cabergoline—Syncope—Betamethasone—ankylosing spondylitis	0.00192	0.00269	CcSEcCtD
Cabergoline—Syncope—Dexamethasone—ankylosing spondylitis	0.00192	0.00269	CcSEcCtD
Cabergoline—Arrhythmia—Prednisone—ankylosing spondylitis	0.00191	0.00268	CcSEcCtD
Cabergoline—Shock—Triamcinolone—ankylosing spondylitis	0.00189	0.00265	CcSEcCtD
Cabergoline—Insomnia—Prednisolone—ankylosing spondylitis	0.00189	0.00265	CcSEcCtD
Cabergoline—Alopecia—Prednisone—ankylosing spondylitis	0.00189	0.00265	CcSEcCtD
Cabergoline—Shock—Methylprednisolone—ankylosing spondylitis	0.00189	0.00265	CcSEcCtD
Cabergoline—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00188	0.00264	CcSEcCtD
Cabergoline—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00188	0.00264	CcSEcCtD
Cabergoline—Epistaxis—Methotrexate—ankylosing spondylitis	0.00188	0.00263	CcSEcCtD
Cabergoline—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00188	0.00263	CcSEcCtD
Cabergoline—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00186	0.00261	CcSEcCtD
Cabergoline—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00185	0.0026	CcSEcCtD
Cabergoline—Hypertension—Dexamethasone—ankylosing spondylitis	0.00184	0.00259	CcSEcCtD
Cabergoline—Hypertension—Betamethasone—ankylosing spondylitis	0.00184	0.00259	CcSEcCtD
Cabergoline—Anxiety—Dexamethasone—ankylosing spondylitis	0.00181	0.00254	CcSEcCtD
Cabergoline—Anxiety—Betamethasone—ankylosing spondylitis	0.00181	0.00254	CcSEcCtD
Cabergoline—Discomfort—Dexamethasone—ankylosing spondylitis	0.0018	0.00252	CcSEcCtD
Cabergoline—Discomfort—Betamethasone—ankylosing spondylitis	0.0018	0.00252	CcSEcCtD
Cabergoline—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00179	0.00252	CcSEcCtD
Cabergoline—Pain—Prednisolone—ankylosing spondylitis	0.00179	0.00251	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00175	0.00246	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00175	0.00245	CcSEcCtD
Cabergoline—Oedema—Betamethasone—ankylosing spondylitis	0.00174	0.00245	CcSEcCtD
Cabergoline—Oedema—Dexamethasone—ankylosing spondylitis	0.00174	0.00245	CcSEcCtD
Cabergoline—Insomnia—Triamcinolone—ankylosing spondylitis	0.00174	0.00244	CcSEcCtD
Cabergoline—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00173	0.00243	CcSEcCtD
Cabergoline—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00173	0.00242	CcSEcCtD
Cabergoline—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00173	0.00242	CcSEcCtD
Cabergoline—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00172	0.00242	CcSEcCtD
Cabergoline—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00172	0.00242	CcSEcCtD
Cabergoline—Visual impairment—Methotrexate—ankylosing spondylitis	0.00172	0.00242	CcSEcCtD
Cabergoline—Shock—Dexamethasone—ankylosing spondylitis	0.00172	0.00241	CcSEcCtD
Cabergoline—Shock—Betamethasone—ankylosing spondylitis	0.00172	0.00241	CcSEcCtD
Cabergoline—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00171	0.00241	CcSEcCtD
Cabergoline—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00169	0.00237	CcSEcCtD
Cabergoline—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00169	0.00237	CcSEcCtD
Cabergoline—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00169	0.00237	CcSEcCtD
Cabergoline—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00169	0.00237	CcSEcCtD
Cabergoline—Malaise—Prednisone—ankylosing spondylitis	0.00168	0.00236	CcSEcCtD
Cabergoline—Vertigo—Prednisone—ankylosing spondylitis	0.00167	0.00235	CcSEcCtD
Cabergoline—Syncope—Prednisone—ankylosing spondylitis	0.00167	0.00234	CcSEcCtD
Cabergoline—Anorexia—Dexamethasone—ankylosing spondylitis	0.00166	0.00233	CcSEcCtD
Cabergoline—Anorexia—Betamethasone—ankylosing spondylitis	0.00166	0.00233	CcSEcCtD
Cabergoline—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00166	0.00233	CcSEcCtD
Cabergoline—Fatigue—Triamcinolone—ankylosing spondylitis	0.00166	0.00233	CcSEcCtD
Cabergoline—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00165	0.00232	CcSEcCtD
Cabergoline—Pain—Triamcinolone—ankylosing spondylitis	0.00164	0.00231	CcSEcCtD
Cabergoline—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00164	0.0023	CcSEcCtD
Cabergoline—Hypotension—Dexamethasone—ankylosing spondylitis	0.00163	0.00229	CcSEcCtD
Cabergoline—Hypotension—Betamethasone—ankylosing spondylitis	0.00163	0.00229	CcSEcCtD
Cabergoline—Hypertension—Prednisone—ankylosing spondylitis	0.00161	0.00226	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00159	0.00223	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00159	0.00223	CcSEcCtD
Cabergoline—Arthralgia—Prednisone—ankylosing spondylitis	0.00158	0.00222	CcSEcCtD
Cabergoline—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00158	0.00222	CcSEcCtD
Cabergoline—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00158	0.00222	CcSEcCtD
Cabergoline—Anxiety—Prednisone—ankylosing spondylitis	0.00158	0.00222	CcSEcCtD
Cabergoline—Alopecia—Methotrexate—ankylosing spondylitis	0.00158	0.00222	CcSEcCtD
Cabergoline—Insomnia—Dexamethasone—ankylosing spondylitis	0.00158	0.00221	CcSEcCtD
Cabergoline—Insomnia—Betamethasone—ankylosing spondylitis	0.00158	0.00221	CcSEcCtD
Cabergoline—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00157	0.0022	CcSEcCtD
Cabergoline—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00157	0.0022	CcSEcCtD
Cabergoline—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00157	0.0022	CcSEcCtD
Cabergoline—Discomfort—Prednisone—ankylosing spondylitis	0.00157	0.0022	CcSEcCtD
Cabergoline—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00154	0.00216	CcSEcCtD
Cabergoline—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00154	0.00215	CcSEcCtD
Cabergoline—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00154	0.00215	CcSEcCtD
Cabergoline—Oedema—Prednisone—ankylosing spondylitis	0.00152	0.00213	CcSEcCtD
Cabergoline—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00152	0.00213	CcSEcCtD
Cabergoline—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00152	0.00213	CcSEcCtD
Cabergoline—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00152	0.00213	CcSEcCtD
Cabergoline—Back pain—Methotrexate—ankylosing spondylitis	0.0015	0.00211	CcSEcCtD
Cabergoline—Fatigue—Betamethasone—ankylosing spondylitis	0.0015	0.00211	CcSEcCtD
Cabergoline—Fatigue—Dexamethasone—ankylosing spondylitis	0.0015	0.00211	CcSEcCtD
Cabergoline—Shock—Prednisone—ankylosing spondylitis	0.00149	0.0021	CcSEcCtD
Cabergoline—Pain—Dexamethasone—ankylosing spondylitis	0.00149	0.00209	CcSEcCtD
Cabergoline—Pain—Betamethasone—ankylosing spondylitis	0.00149	0.00209	CcSEcCtD
Cabergoline—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00147	0.00206	CcSEcCtD
Cabergoline—Anorexia—Prednisone—ankylosing spondylitis	0.00145	0.00203	CcSEcCtD
Cabergoline—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00144	0.00203	CcSEcCtD
Cabergoline—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00144	0.00202	CcSEcCtD
Cabergoline—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00144	0.00202	CcSEcCtD
Cabergoline—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00143	0.002	CcSEcCtD
Cabergoline—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00143	0.002	CcSEcCtD
Cabergoline—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00142	0.00199	CcSEcCtD
Cabergoline—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00141	0.00198	CcSEcCtD
Cabergoline—Malaise—Methotrexate—ankylosing spondylitis	0.0014	0.00197	CcSEcCtD
Cabergoline—Vertigo—Methotrexate—ankylosing spondylitis	0.0014	0.00196	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00138	0.00194	CcSEcCtD
Cabergoline—Dizziness—Prednisolone—ankylosing spondylitis	0.00138	0.00194	CcSEcCtD
Cabergoline—Asthenia—Triamcinolone—ankylosing spondylitis	0.00138	0.00194	CcSEcCtD
Cabergoline—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00138	0.00194	CcSEcCtD
Cabergoline—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00138	0.00194	CcSEcCtD
Cabergoline—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00138	0.00193	CcSEcCtD
Cabergoline—Insomnia—Prednisone—ankylosing spondylitis	0.00137	0.00193	CcSEcCtD
Cabergoline—Paraesthesia—Prednisone—ankylosing spondylitis	0.00136	0.00191	CcSEcCtD
Cabergoline—Pruritus—Triamcinolone—ankylosing spondylitis	0.00136	0.00191	CcSEcCtD
Cabergoline—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00136	0.0019	CcSEcCtD
Cabergoline—Dyspepsia—Prednisone—ankylosing spondylitis	0.00134	0.00188	CcSEcCtD
Cabergoline—Arthralgia—Methotrexate—ankylosing spondylitis	0.00132	0.00186	CcSEcCtD
Cabergoline—Decreased appetite—Prednisone—ankylosing spondylitis	0.00132	0.00185	CcSEcCtD
Cabergoline—Rash—Prednisolone—ankylosing spondylitis	0.00132	0.00185	CcSEcCtD
Cabergoline—Dermatitis—Prednisolone—ankylosing spondylitis	0.00132	0.00185	CcSEcCtD
Cabergoline—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00131	0.00184	CcSEcCtD
Cabergoline—Fatigue—Prednisone—ankylosing spondylitis	0.00131	0.00184	CcSEcCtD
Cabergoline—Headache—Prednisolone—ankylosing spondylitis	0.00131	0.00184	CcSEcCtD
Cabergoline—Discomfort—Methotrexate—ankylosing spondylitis	0.00131	0.00184	CcSEcCtD
Cabergoline—Constipation—Prednisone—ankylosing spondylitis	0.0013	0.00182	CcSEcCtD
Cabergoline—Confusional state—Methotrexate—ankylosing spondylitis	0.00128	0.0018	CcSEcCtD
Cabergoline—Dizziness—Triamcinolone—ankylosing spondylitis	0.00127	0.00178	CcSEcCtD
Cabergoline—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00127	0.00178	CcSEcCtD
Cabergoline—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00125	0.00176	CcSEcCtD
Cabergoline—Asthenia—Betamethasone—ankylosing spondylitis	0.00125	0.00176	CcSEcCtD
Cabergoline—Asthenia—Dexamethasone—ankylosing spondylitis	0.00125	0.00176	CcSEcCtD
Cabergoline—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00124	0.00174	CcSEcCtD
Cabergoline—Nausea—Prednisolone—ankylosing spondylitis	0.00124	0.00174	CcSEcCtD
Cabergoline—Pruritus—Dexamethasone—ankylosing spondylitis	0.00123	0.00173	CcSEcCtD
Cabergoline—Pruritus—Betamethasone—ankylosing spondylitis	0.00123	0.00173	CcSEcCtD
Cabergoline—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00123	0.00172	CcSEcCtD
Cabergoline—Vomiting—Triamcinolone—ankylosing spondylitis	0.00122	0.00172	CcSEcCtD
Cabergoline—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00122	0.00171	CcSEcCtD
Cabergoline—Rash—Triamcinolone—ankylosing spondylitis	0.00121	0.0017	CcSEcCtD
Cabergoline—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00121	0.0017	CcSEcCtD
Cabergoline—Anorexia—Methotrexate—ankylosing spondylitis	0.00121	0.0017	CcSEcCtD
Cabergoline—Rash—Methylprednisolone—ankylosing spondylitis	0.00121	0.0017	CcSEcCtD
Cabergoline—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00121	0.0017	CcSEcCtD
Cabergoline—Headache—Triamcinolone—ankylosing spondylitis	0.0012	0.00169	CcSEcCtD
Cabergoline—Headache—Methylprednisolone—ankylosing spondylitis	0.0012	0.00169	CcSEcCtD
Cabergoline—Abdominal pain—Prednisone—ankylosing spondylitis	0.0012	0.00169	CcSEcCtD
Cabergoline—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00119	0.00167	CcSEcCtD
Cabergoline—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00119	0.00167	CcSEcCtD
Cabergoline—Hypotension—Methotrexate—ankylosing spondylitis	0.00119	0.00166	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00116	0.00162	CcSEcCtD
Cabergoline—Dizziness—Betamethasone—ankylosing spondylitis	0.00115	0.00162	CcSEcCtD
Cabergoline—Dizziness—Dexamethasone—ankylosing spondylitis	0.00115	0.00162	CcSEcCtD
Cabergoline—Insomnia—Methotrexate—ankylosing spondylitis	0.00115	0.00161	CcSEcCtD
Cabergoline—Nausea—Triamcinolone—ankylosing spondylitis	0.00114	0.0016	CcSEcCtD
Cabergoline—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00114	0.0016	CcSEcCtD
Cabergoline—Nausea—Methylprednisolone—ankylosing spondylitis	0.00114	0.0016	CcSEcCtD
Cabergoline—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00113	0.00159	CcSEcCtD
Cabergoline—Somnolence—Methotrexate—ankylosing spondylitis	0.00113	0.00158	CcSEcCtD
Cabergoline—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00112	0.00157	CcSEcCtD
Cabergoline—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00112	0.00157	CcSEcCtD
Cabergoline—Vomiting—Dexamethasone—ankylosing spondylitis	0.00111	0.00156	CcSEcCtD
Cabergoline—Vomiting—Betamethasone—ankylosing spondylitis	0.00111	0.00156	CcSEcCtD
Cabergoline—Decreased appetite—Methotrexate—ankylosing spondylitis	0.0011	0.00155	CcSEcCtD
Cabergoline—Rash—Betamethasone—ankylosing spondylitis	0.0011	0.00154	CcSEcCtD
Cabergoline—Rash—Dexamethasone—ankylosing spondylitis	0.0011	0.00154	CcSEcCtD
Cabergoline—Dermatitis—Betamethasone—ankylosing spondylitis	0.0011	0.00154	CcSEcCtD
Cabergoline—Dermatitis—Dexamethasone—ankylosing spondylitis	0.0011	0.00154	CcSEcCtD
Cabergoline—Fatigue—Methotrexate—ankylosing spondylitis	0.00109	0.00154	CcSEcCtD
Cabergoline—Headache—Betamethasone—ankylosing spondylitis	0.00109	0.00153	CcSEcCtD
Cabergoline—Headache—Dexamethasone—ankylosing spondylitis	0.00109	0.00153	CcSEcCtD
Cabergoline—Asthenia—Prednisone—ankylosing spondylitis	0.00109	0.00153	CcSEcCtD
Cabergoline—Pain—Methotrexate—ankylosing spondylitis	0.00109	0.00152	CcSEcCtD
Cabergoline—Pruritus—Prednisone—ankylosing spondylitis	0.00107	0.00151	CcSEcCtD
Cabergoline—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00105	0.00147	CcSEcCtD
Cabergoline—Diarrhoea—Prednisone—ankylosing spondylitis	0.00104	0.00146	CcSEcCtD
Cabergoline—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00104	0.00146	CcSEcCtD
Cabergoline—Nausea—Dexamethasone—ankylosing spondylitis	0.00104	0.00145	CcSEcCtD
Cabergoline—Nausea—Betamethasone—ankylosing spondylitis	0.00104	0.00145	CcSEcCtD
Cabergoline—Dizziness—Prednisone—ankylosing spondylitis	0.001	0.00141	CcSEcCtD
Cabergoline—Abdominal pain—Methotrexate—ankylosing spondylitis	0.001	0.00141	CcSEcCtD
Cabergoline—Vomiting—Prednisone—ankylosing spondylitis	0.000966	0.00136	CcSEcCtD
Cabergoline—Rash—Prednisone—ankylosing spondylitis	0.000958	0.00134	CcSEcCtD
Cabergoline—Dermatitis—Prednisone—ankylosing spondylitis	0.000957	0.00134	CcSEcCtD
Cabergoline—Headache—Prednisone—ankylosing spondylitis	0.000951	0.00134	CcSEcCtD
Cabergoline—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000935	0.00131	CcSEcCtD
Cabergoline—Asthenia—Methotrexate—ankylosing spondylitis	0.000911	0.00128	CcSEcCtD
Cabergoline—Nausea—Prednisone—ankylosing spondylitis	0.000902	0.00127	CcSEcCtD
Cabergoline—Pruritus—Methotrexate—ankylosing spondylitis	0.000898	0.00126	CcSEcCtD
Cabergoline—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000868	0.00122	CcSEcCtD
Cabergoline—Dizziness—Methotrexate—ankylosing spondylitis	0.000839	0.00118	CcSEcCtD
Cabergoline—Vomiting—Methotrexate—ankylosing spondylitis	0.000807	0.00113	CcSEcCtD
Cabergoline—Rash—Methotrexate—ankylosing spondylitis	0.0008	0.00112	CcSEcCtD
Cabergoline—Dermatitis—Methotrexate—ankylosing spondylitis	0.0008	0.00112	CcSEcCtD
Cabergoline—Headache—Methotrexate—ankylosing spondylitis	0.000795	0.00112	CcSEcCtD
Cabergoline—Nausea—Methotrexate—ankylosing spondylitis	0.000754	0.00106	CcSEcCtD
